Klotho has dual protective effects on cisplatin-induced acute kidney injury.
about
Klotho, stem cells, and agingPathophysiology of cisplatin-induced acute kidney injury.α-Klotho protects against oxidative damage in pulmonary epithelia.The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibodyMitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functionsAblation of the p16(INK4a) tumour suppressor reverses ageing phenotypes of klotho miceRenal Klotho expression in patients with acute kidney injury is associated with the severity of the injuryKlotho: a novel and early biomarker of acute kidney injury after cardiac valve replacement surgery in adultsKlotho and S100A8/A9 as Discriminative Markers between Pre-Renal and Intrinsic Acute Kidney InjuryDiabetes Complications in Childhood Diabetes-New Biomarkers and Technologies.Renal Production, Uptake, and Handling of Circulating αKlothoαKlotho deficiency in acute kidney injury contributes to lung damage.High dietary phosphate intake induces hypertension and augments exercise pressor reflex function in rats.Neuropeptide Y protects kidney against cisplatin-induced nephrotoxicity by regulating p53-dependent apoptosis pathway.Elevated serum 1,25(OH)2-vitamin D3 level attenuates renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction in kl/kl mice.Hydrogen-Rich Saline Alleviates Kidney Fibrosis Following AKI and Retains Klotho ExpressionMiR-30c regulates cisplatin-induced apoptosis of renal tubular epithelial cells by targeting Bnip3L and Hspa5.Pharmacotherapeutic options for treating adverse effects of Cisplatin chemotherapy.Effects of Potassium Magnesium Citrate Supplementation on 24-Hour Ambulatory Blood Pressure and Oxidative Stress Marker in Prehypertensive and Hypertensive Subjects.Sclerostin, TNF-alpha and Interleukin-18 Correlate and are Together with Klotho Related to Other Growth Factors and Cytokines in Haemodialysis Patients.Downregulation of kidney protective factors by inflammation: role of transcription factors and epigenetic mechanisms.Potential application of klotho in human chronic kidney disease.Acute lung injury complicating acute kidney injury: A model of endogenous αKlotho deficiency and distant organ dysfunction.αKlotho and Chronic Kidney Disease.Downregulation of autophagy is associated with severe ischemia-reperfusion-induced acute kidney injury in overexpressing C-reactive protein mice.αKlotho Mitigates Progression of AKI to CKD through Activation of AutophagyIn reference to Immunohistochemical localization of OCT2 in the cochlea of various species.In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation.Protective effect of Salvianolic acid A on ischaemia-reperfusion acute kidney injury in rats through protecting against peritubular capillary endothelium damages.Effects of Erythropoietin Receptor Activity on Angiogenesis, Tubular Injury and Fibrosis in Acute Kidney Injury: A "U-Shaped" Relationship.AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms.Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.Necrostatin-1 Attenuates Cisplatin-Induced Nephrotoxicity Through Suppression of Apoptosis and Oxidative Stress and Retains Klotho Expression.Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease.Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review
P2860
Q26783185-1A2B8B21-85F2-4434-A313-C02B45AE2834Q34073302-2B28BDA0-3A0F-4FC0-9A43-38D8A89B964BQ34295265-E78327DB-6D3C-45FB-A44D-F487C35F226EQ35022247-C88C0D32-D8C0-4245-B173-BCB225AA4853Q35549264-D7D763AD-6ED1-4083-89B2-3D8548B6E4B7Q35574809-F4866169-056F-4CB9-9EB0-A9BBEF06C0B3Q35834949-76A45C20-267E-42AC-AEA5-E054A49B4E9EQ35870769-7A37F033-FD80-4927-903F-1F7AB3C97832Q35901176-D3B1E1D6-6055-4896-B4FF-8A70186BF1F8Q36095944-72158AF3-6D21-4C45-A244-8CBF833BF36AQ36417890-6230EC73-B846-426E-977C-49BD38A8A650Q36775310-B475663E-0C37-4EAC-BD51-287761D4E00AQ37139715-38FAEF99-762F-4A8F-9E80-DDC140CBFD1FQ37351157-BC0A6A82-D562-4C04-B03A-59B64CD8D97BQ37734865-3902DE52-B401-41EB-8D69-C70053DAB4C9Q38604911-77926BB8-B6C1-4810-B018-259BFBAC4337Q38630687-4EE40821-BC15-4133-9251-324778CC40CAQ38637751-A2FC8F4B-2D85-4912-8F18-09F9D3317465Q38838722-D31DB1D9-EA2A-45BE-BDBD-C0DC1695837CQ38955348-1DFC4D14-EB31-42CF-BF72-D6B2AF6F3778Q38985548-B216D981-7FE2-42F8-8287-DF1DA2679F5AQ39003568-5F7EAB12-122C-44BB-8BE1-8B4238833B08Q39203308-3727C5C5-75D0-4A83-8495-03D8FE4FD07AQ39812781-8ABD91C5-3D89-4E98-A35A-4E9D54744E20Q41501004-DEC4BB12-B0D5-448C-A0D5-F159D856082FQ42123327-66FF10D2-92B5-4517-A516-95F57AC1EA7FQ46597803-23A3B6EC-48FC-42BA-AE13-6DD29B26405FQ46727259-4D4038EA-BAA1-4921-88D3-1BA943910D6FQ47601871-A218E09E-32EB-47AD-807F-C0028A7D66FFQ49541601-4DBCAE4A-E7BA-4EE5-BA1E-8B87B07AFBE6Q50175524-83C02EF3-5DDF-40DA-9EB5-FA8EBD100CA2Q51164635-A8D13DB8-63EF-4074-B8C4-57B744E6062CQ54112511-366B4CCC-E7BE-43DF-92B0-50C44C83E2C3Q55442487-E4B7F401-6126-4B2C-AAA4-6094E0CF02BBQ57490969-E421F1DA-6DA9-43FB-BA2C-105707832B75
P2860
Klotho has dual protective effects on cisplatin-induced acute kidney injury.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Klotho has dual protective effects on cisplatin-induced acute kidney injury.
@en
Klotho has dual protective effects on cisplatin-induced acute kidney injury.
@nl
type
label
Klotho has dual protective effects on cisplatin-induced acute kidney injury.
@en
Klotho has dual protective effects on cisplatin-induced acute kidney injury.
@nl
prefLabel
Klotho has dual protective effects on cisplatin-induced acute kidney injury.
@en
Klotho has dual protective effects on cisplatin-induced acute kidney injury.
@nl
P2093
P2860
P356
P1433
P1476
Klotho has dual protective effects on cisplatin-induced acute kidney injury.
@en
P2093
Jianfeng Ye
Ming Chang Hu
Mingjun Shi
Monica C Panesso
Orson W Moe
P2860
P2888
P304
P356
10.1038/KI.2013.489
P407
P577
2013-12-04T00:00:00Z